- Home
- ALVR vs KOSS Comparison
ALVR vs KOSS Comparison
Compare ALVR & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- KOSS
- Stock Information
- Founded
- ALVR 2013
- KOSS 1953
- Country
- ALVR United States
- KOSS United States
- Employees
- ALVR N/A
- KOSS N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- KOSS Consumer Electronics/Appliances
- Sector
- ALVR Health Care
- KOSS Consumer Staples
- Exchange
- ALVR Nasdaq
- KOSS Nasdaq
- Market Cap
- ALVR 87.7M
- KOSS 63.0M
- IPO Year
- ALVR 2020
- KOSS N/A
- Fundamental
- Price
- ALVR $0.94
- KOSS $7.34
- Analyst Decision
- ALVR Sell
- KOSS
- Analyst Count
- ALVR 5
- KOSS 0
- Target Price
- ALVR $1.00
- KOSS N/A
- AVG Volume (30 Days)
- ALVR 155.6K
- KOSS 183.8K
- Earning Date
- ALVR 11-04-2024
- KOSS 11-08-2024
- Dividend Yield
- ALVR N/A
- KOSS N/A
- EPS Growth
- ALVR N/A
- KOSS N/A
- EPS
- ALVR N/A
- KOSS N/A
- Revenue
- ALVR N/A
- KOSS $12,265,069.00
- Revenue This Year
- ALVR N/A
- KOSS N/A
- Revenue Next Year
- ALVR N/A
- KOSS N/A
- P/E Ratio
- ALVR N/A
- KOSS N/A
- Revenue Growth
- ALVR N/A
- KOSS N/A
- 52 Week Low
- ALVR $0.58
- KOSS $2.27
- 52 Week High
- ALVR $2.49
- KOSS $18.73
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- KOSS 50.17
- Support Level
- ALVR $0.74
- KOSS $7.00
- Resistance Level
- ALVR $0.91
- KOSS $7.83
- Average True Range (ATR)
- ALVR 0.06
- KOSS 0.44
- MACD
- ALVR 0.01
- KOSS -0.01
- Stochastic Oscillator
- ALVR 94.50
- KOSS 32.26
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.